New legal documents filed by Dana-Farber Cancer Institute delve further into the organization’s reasoning for its $1.68 billion endeavor to establish a standalone cancer hospital in partnership with Beth Israel Deaconess Medical Center, The Boston Globe reported Oct. 25.
Read the full post on Becker's Hospital Review - Healthcare News